Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 07:23 am Purchase |
2024-09-30 | 13G | Kyverna Therapeutics, Inc. KYTX |
Westlake BioPartners Fund I L.P. | 4,523,924 10.500% |
4,523,924 (New Position) |
Filing History |
| 2024-10-10 12:36 pm Purchase |
2024-09-30 | 13G | Kyverna Therapeutics, Inc. KYTX |
J P MORGAN CHASE & CO JPM |
2,380,021 5.500% |
2,380,021 (New Position) |
Filing History |
| 2024-05-03 5:57 pm Purchase |
2024-02-12 | 13D | Kyverna Therapeutics, Inc. KYTX |
Vida Ventures LLC | 4,777,060 11.100% |
4,777,060 (New Position) |
Filing History |
| 2024-02-22 4:29 pm Purchase |
2024-02-12 | 13G | Kyverna Therapeutics, Inc. KYTX |
Northpond Ventures III LP | 3,255,426 7.600% |
3,255,426 (New Position) |
Filing History |
| 2024-02-20 4:31 pm Purchase |
2024-02-12 | 13G | Kyverna Therapeutics, Inc. KYTX |
GILEAD SCIENCES INC GILD |
4,126,119 9.600% |
4,126,119 (New Position) |
Filing History |
| 2024-02-14 5:20 pm Purchase |
2024-02-07 | 13G | Kyverna Therapeutics, Inc. KYTX |
Bain Capital Life Sciences Opportunities III, LP | 3,163,868 7.400% |
3,163,868 (New Position) |
Filing History |